AVID ALOE

What this means for you

Not registered yet, but its 23 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97765061

Mark type

Design + words

Filed

23 Jan 2023

Published for opposition

29 Aug 2023

Attorney of record

Lisa L. Mueller

Goods and services

• Class 001 — Chemicals: Biological preparations derived from genetically modified aloe plants, aloe tissues, aloe cells, and aloe seeds, and from byproducts of genetically modified aloe plants, aloe tissues, aloe cells, and aloe seeds for use in the manufacture of cosmetics, personal care products, nutraceuticals, pharmaceuticals, therapeutic agents, therapeutic compositions, topical application products, soaps, oils, gels, creams, lotions, waxes, ointments, adhesives, dietary products, nutritional products, food products, food supplements, vitamin supplements, dietary supplements, nutritional ingredients, food preparation ingredients, processed foods, non-alcoholic drinks, beverages, waters, juices, extracts, ciders, ales, beers, nectars, syrups, elixirs, milks, essences, powders, liqueurs, sherbets, sorbets, shakes, ices, smoothies, seltzers, none of the foregoing for medical or veterinary use
• Class 003 — Cosmetics and cleaning preparations: Biological preparations derived from genetically modified aloe plants, aloe tissues, aloe cells, and aloe gels, and from any byproduct of genetically modified aloe plants, aloe tissues, aloe cells and aloe seeds, for use as cosmetics and personal care products, namely, nonmedicated soaps, body oils, body gels, skin creams, skin lotions, non-medicated skin ointments, and body powders
• Class 005 — Pharmaceuticals: Biological preparations derived from genetically modified aloe plants, aloe tissues, aloe cells, and aloe gels, and from byproducts of genetically modified aloe plants, aloe tissues, aloe cells, and aloe seeds for the treatment of dermatopathologies, heart disease, liver disease, kidney disease, lung disease, microbial infection, viral infection, fungal infection, arthritis, vascular disease, dental disease, periodontal disease, oral disease, sinus disease, auditory disease, neurological disease, gastrointestinal disease, renal disease, degenerative muscular disease, degenerative neurological disease, ophthalmological disease, ocular disease, olfactory disease, obstetrical disease, gynecological disease, urinary disease, thyroid disease, cancer, lymphoma, leukemia, non-malignant tumors, fibroid disease, chronic fatigue syndrome, mononucleosis, multiple sclerosis, muscular dystrophy, autism, autism spectrum disorder, pervasive personality disorder, attention deficit hyperactivity disorder (ADHD), attention deficit disorder (ADD), dysgraphia, dyslexia, mental health disease, bipolar disorder, depression, schizophrenia, failure to thrive, chronic wasting disease, Alzheimer's disease, diabetes, and for the growth and repair of body tissue, for veterinary and medical use

Owner

• TheGreenCell, Inc., Washington, DC, US
• TheGreenCell, Inc., Washington, DC, US

Prosecution history

• 27 Mar 2026 — SOU TEAS EXTENSION RECEIVED
• 13 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 13 Jan 2026 — SOU EXTENSION 4 GRANTED
• 23 Oct 2025 — SOU EXTENSION 4 FILED
• 12 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 27 Oct 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
• 27 Oct 2025 — NOTICE OF REVIVAL - E-MAILED
• 27 Oct 2025 — PETITION TO REVIVE-GRANTED
• 27 Oct 2025 — TEAS PETITION TO REVIVE RECEIVED
• 24 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 24 Apr 2025 — SOU EXTENSION 3 GRANTED
• 23 Apr 2025 — SOU EXTENSION 3 FILED
• 23 Apr 2025 — SOU TEAS EXTENSION RECEIVED
• 22 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 22 Oct 2024 — SOU EXTENSION 2 GRANTED